What Researchers Did
The authors wrote a review of how radiation damages skin, why it can lead to long-lasting ulcers, and what the literature says about preventing and treating them.
What They Found
This review of the literature on ulcers in radiated skin found that the evidence for most preventive measures is inconclusive, and that the strongest level of evidence for treating ulcers was for pentoxifylline. The abstract names sucralfate and amifostine as seeming to be adequate recommendations for prophylaxis. For treatment, pentoxifylline had the strongest evidence, but proper trials are still scarce, so it is not yet considered a standard adjuvant therapy. Hyperbaric oxygen, cytokines and other growth factors, and surgical interventions have shown some benefit in case reports and case series only. Other therapies show promise based on how they work but still need to be tested in human studies and clinical trials.
What This Means for Canadian Patients
For people with ulcers in radiated skin, this review says hyperbaric oxygen has shown some benefit in case reports and case series only. Those designs cannot show that the treatment caused the improvement. The review also says pentoxifylline had the strongest evidence of the treatments it covered, though even that is not yet considered standard. The abstract gives no HBOT pressures or session numbers. Patients should discuss options with their care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a narrative review rather than a trial, and the authors state that proper trials are scarce, that evidence for most preventive measures is inconclusive, and that hyperbaric oxygen is supported only by case reports and case series.